A year ago, President Trump pledged to lower Medicaid drug prices. Has that happened?

A year after President Trump promised to reduce Medicaid drug prices, the actual changes remain uncertain. His administration proposed alterations that would affect drug costs, but states must choose to participate. This delay and variability mean that many beneficiaries are still paying high prices for medications. The issue is significant as it affects millions of low-income Americans relying on Medicaid for essential healthcare services, highlighting ongoing challenges in healthcare policy and cost control.